Sector ratings Changchun BCHT Biotechnology Co.

Equities

End-of-day quote Shanghai S.E. Other stock markets 2025-12-11			5-day change	1st Jan Change
19.71 ^CNY	-3.05%		-7.72%	-21.51%

11-13	BCHT Biotechnology Gets Nod to Trial Vaccines Against Pertussis, Diphtheria, Tetanus	MT
10-30	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
CHANGCHUN BCHT BIOTECHNOLOGY CO.	1.19B		-			-
MERCK KGAA	58.89B		AAA
KYOWA KIRIN CO., LTD.	8.49B		AA
HALOZYME THERAPEUTICS, INC.	7.37B		BBB
SK BIOPHARMACEUTICALS CO., LTD.	7.25B		AAA
YUHAN CORPORATION	5.89B		AA
INDIVIOR PLC	4.43B	-	BBB	-		-
BETTA PHARMACEUTICALS CO., LTD.	2.9B		-
SUPERNUS PHARMACEUTICALS, INC.	2.65B	-	BB	-		-
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	2.5B	-	-	-		-	-	-
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	1.93B	-	-	-		-	-	-
VELOXIS PHARMACEUTICALS A/S	1.64B	-	-	-	-	-	-	-
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	1.62B	-	-	-		-	-
MEZZION PHARMA CO.,LTD.	1.57B	-	BBB	-	-	-	-	-
OSCOTEC INC.	1.55B		B
YOUCARE PHARMACEUTICAL GROUP CO., LTD.	1.53B	-	-	-		-	-	-
SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.	1.33B	-	-	-	-	-	-	-
KISSEI PHARMACEUTICAL CO., LTD.	1.23B		BB			-
FRONTIER BIOTECHNOLOGIES INC.	1B	-	-	-	-	-	-	-
HK INNO.N CORPORATION	996M		BBB
Average	5.8B		A
Weighted average by Cap.			A